Hints and tips:
...Glaxo first bought Wellcome in 1995 and then SmithKline Beecham in 2000, becoming GSK. Glencore acquired Xstrata in 2013....
...It was under his successor, Sir Richard Sykes, that Glaxo undertook two major transactions — acquiring Wellcome in 1995 and merging with SmithKline Beecham in 2000 — which radically altered the portfolio...
...SmithKline Beecham (now part of GSK) pulled its successful Lyme disease vaccine in the early 2000s amid rising anti-vaccine sentiment....
...whether his ambitious “five-pillar” plan — engaging the private sector in testing and trying to develop a “huge diagnostic industry” almost from scratch involving big companies like AstraZeneca and Glaxo SmithKline...
...He pointed to the merger, almost 20 years ago, of Glaxo Wellcome with SmithKline Beecham, creating global behemoth GSK, which demonstrated that “the process was not as easily ‘industrialisable’ as people...
...Perhaps some remembered who made Tagamet, and what became of them: a little outfit by the name of SmithKline....
...Nor have Glaxo and SmithKline Beecham. Telecoms groups have long claimed they need mergers to compete — most recently in the US and Europe....
...Beecham....
...Beecham to create GSK....
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...I was an investor in Glaxo Wellcome and SmithKline Beecham through most of the 1990s, before their merger into one entity....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...Megamergers such as Pfizer’s $90bn takeover of Warner-Lambert in 1999 and SmithKline’s $72bn merger with Glaxo had struggled to produce growth....
...Glaxo began a programme of consolidation of the UK drug industry in the mid-nineties by first merging with Wellcome and, subsequently, with SmithKline Beecham....
...A Pfizer-AstraZeneca deal would rival the $74bn merger between GlaxoWellcome and SmithKline Beecham in 2000 as the biggest in industry history, and outstrip Pfizer’s own record $68bn acquisition of Wyeth...
...A chartered accountant, he joined SmithKline, a predecessor company of GSK, in 1989....
...Mr Metcalfe says no amount of time will undo his relationship with Mr Beecham....
...Then comes the Beecham, on the site of a former Lloyds Bank and Pizza Hut, with seven units due for completion in early 2013....
...Every Kenyan – it doesn’t matter where they are – their dreams and aspirations are resident in Nairobi,” says the pro-business Mr Kidero, once a managing director with SmithKline Beecham....
...An MBA at Cranfield followed, and he landed a marketing job at SmithKline Beecham as assistant product manager of Instant Horlicks, a powdered drink....
...Brook is managing director of Leapfrog Research and Planning, a brand research agency, and was a board director at global brand agency Distillery during the 1990s, working with clients such as Unilever, Beecham...
...“We should go for a combined authority of local authorities in Tyne and Wear and probably Northumberland to do the sub-regional things,” said Lord Beecham, a former Labour leader of Newcastle city council...
...As Glaxo Wellcome chief, he oversaw its merger with SmithKline Beecham in 2000, and stepped down in 2002 at the age of 60....
...He was also finance director at BG Group and chief financial officer at SmithKline Beecham, which merged with Glaxo Wellcome in 2000 to createGlaxoSmithKline....
International Edition